Vivos Therapeutics Inc [NASDAQ: VVOS] gained 3.53% on the last trading session, reaching $3.52 price per share at the time.
Vivos Therapeutics Inc represents 7.32 million in outstanding shares, while the company has a total market value of $26.42 million with the latest information. VVOS stock price has been found in the range of $3.17 to $3.7.
If compared to the average trading volume of 750.92K shares, VVOS reached a trading volume of 5410986 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Vivos Therapeutics Inc [VVOS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VVOS shares is $5.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VVOS stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 5.63, with the Price to Cash per share for the same quarter was set at 0.59.
Trading performance analysis for VVOS stock
Vivos Therapeutics Inc [VVOS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.61. With this latest performance, VVOS shares dropped by -20.90% in over the last four-week period, additionally sinking by -0.85% over the last 6 months – not to mention a drop of -17.95% in the past year of trading.
Vivos Therapeutics Inc [VVOS]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Vivos Therapeutics Inc [VVOS] shares currently have an operating margin of -98.89% and a Gross Margin at 50.56%. Vivos Therapeutics Inc’s Net Margin is presently recorded at -99.49%.
Vivos Therapeutics Inc (VVOS) Capital Structure & Debt Analysis
According to recent financial data for Vivos Therapeutics Inc. ( VVOS), the Return on Equity (ROE) stands at -262.03%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -68.39%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Vivos Therapeutics Inc’s Return on Invested Capital (ROIC) is -93.61%, showcasing its effectiveness in deploying capital for earnings.
Vivos Therapeutics Inc (VVOS) Efficiency & Liquidity Metrics
Based on Vivos Therapeutics Inc’s (VVOS) latest financial statements, the Debt-to-Equity Ratio is 2.53%, indicating its reliance on debt financing relative to shareholder equity.
Vivos Therapeutics Inc (VVOS) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Vivos Therapeutics Inc. (VVOS) effectively leverages its workforce, generating an average of -$131376.15 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.05% and a Quick Ratio of 1.05%, indicating strong ability to cover short-term liabilities.
Vivos Therapeutics Inc [VVOS]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Vivos Therapeutics Inc posted -0.4/share EPS, while the average EPS was predicted by analysts to be reported at -0.7/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.3. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for VVOS.
An analysis of Institutional ownership at Vivos Therapeutics Inc [VVOS]
There are presently around $10.57%, or 14.99%% of VVOS stock, in the hands of institutional investors. The top three institutional holders of VVOS stocks are: STRATEGIC WEALTH INVESTMENT GROUP, LLC with ownership of 0.13 million shares, which is approximately 3.9893%. GEODE CAPITAL MANAGEMENT, LLC, holding 20691.0 shares of the stock with an approximate value of $$45933.0 in VVOS stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $$36000.0 in VVOS stock with ownership which is approximately 0.4956%.
